Modified mammalian cells
TW202639840APending Publication Date: 2026-10-01GENENTECH INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115105636
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-03-01
- Filing Date
- 2021-03-26
- Publication Date
- 2026-10-01
Smart Images

Figure TWG2TA001079350_001 
Figure TWG2TA001079350_002 
Figure TWG2TA001079350_003
Abstract
The present disclosure relates to methods, cells, and compositions for producing a product of interest, e.g., a recombinant protein. In particular, the present disclosure provides improved mammalian cells expressing the product of interest, where the cells (e.g., Chinese Hamster Ovary (CHO) cells) have reduced or eliminated activity, e.g., expression, of certain host cell proteins, e.g., enzymes including, but not limited to, certain lipases, esterases, and / or hydrolases.
Need to check novelty before this filing date? Find Prior Art
